loading
loading
Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33% - Published OnOct 30, 2026 | 14:30 IST - Last Updated OnOct 30, 2026 | 14:30 IST At the operating level, the company reported EBITDA of ₹547.6 crore for the quarter. Its EBITDA margin expanded to 30.5% from 24.2% in the corresponding period last year. Shares of Ajanta Pharma Ltd. were trading higher on Friday, October 30, after the pharmaceutical company reported a strong set of results for the September quarter of FY27, with net profit and revenue registering healthy year-on-year growth. Ajanta Pharma's net profit rose 49% to ₹388 crore in Q2 FY27, compared with ₹260.2 crore in the corresponding quarter last year. Revenue from operations increased 32.5% year-on-year to ₹1,794.2 crore, against ₹1,354 crore in the year-ago period. At the operating level, the company reported EBITDA of ₹547.6 crore for the quarter. Its EBITDA margin expanded to 30.5% from 24.2% in the corresponding period last year. Following the results announcement, Ajanta Pharma shares were trading 2.67% higher at ₹3,552.10 on Friday. More from Market Sun Pharma Q2 Results: US sales meet expectations; Other parameters deliver a beat Oct 30, 2026 Network18 Q2 Results: Revenue growth of 9% despite industry headwinds; Operating EBITDA positive Oct 30, 2026 Intellect Design Arena Q2: Shares plunge 8.5% on margin contraction, subdued profit growth Oct 30, 2026
document fetched 2026-10-31 02:56 · canonical https://cnbctv18.com/market/ajanta-pharma-share-price-q2-results-net-profit-rises-revenue-up-20023298.htm